Valid Ghana · FDA Ghana

POLIOMYELITIS VACCINE

ORAL, BIVALENT TYPE 1 AND 3

FDA/HVC/255-03004 ORAL, BIVALENT TYPE 1 AND 3 0.1ML/DOSE (20 DOSES)

What it does

Bivalent is a type of medication used to help protect against certain diseases.

Commonly used for: prevention of infectious diseases

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/HVC/255-03004
Registration date
2025-03-25
Expiry date
2030-04-01
Status
Valid
Active ingredient
ORAL, BIVALENT TYPE 1 AND 3
Strength
0.1ML/DOSE (20 DOSES)
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Serum Institute Of India
Country of origin
INDIA
Manufacturer location
Serum Institute Of India, 212/2, off Soli Poonawalla Road, Parijat Colony, Sadhana Society, Hadapsar, Pune, Maharashtra 411028, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:48:18 · updated 2026-10-20 04:00:05

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Bivalent is a type of medication used to help protect against certain diseases.

What it treats

  • prevention of infectious diseases

How it works

Bivalent works by stimulating the body's immune system to recognize and fight off specific pathogens.

Who it's for

Bivalent is suitable for individuals looking to prevent certain infections, often recommended for specific age groups or health conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: bivalent

Bivalent vaccines are immunological preparations that contain two different antigens or two different strains of the same antigen. They are designed to elicit an immune response against multiple pathogens or variants, enhancing the breadth of protection. These vaccines are used in various infectious diseases, including influenza, human papillomavirus, and others.

Indications

  • Prevention of influenza
  • Prevention of human papillomavirus infection
  • Prevention of certain bacterial infections

Dosage

Children: Refer to specific bivalent vaccine product information for paediatric dosing guidelines.

Adults: Refer to specific bivalent vaccine product information for dosing guidelines.

Mechanism of action

Bivalent vaccines work by introducing two distinct antigens into the body, which stimulates the immune system to recognize and respond to both antigens. This results in the production of antibodies specific to each antigen, leading to immunological memory that can provide protection against future infections with those pathogens.

Pharmacodynamics

The pharmacodynamics of bivalent vaccines involve the activation of both humoral and cellular immune responses. Upon administration, antigen-presenting cells capture the vaccine antigens, process them, and present them to T cells. This leads to the activation of T helper cells, which in turn stimulate B cells to produce antibodies. The antibodies neutralize the pathogens and mark them for destruction by other immune cells. The robust immune response aims to provide long-lasting protection against the targeted diseases.

Pharmacokinetics

The pharmacokinetics of bivalent vaccines primarily involve the absorption of antigens into the body, the distribution of these antigens to lymphoid tissues, and the subsequent immune response. Vaccines are typically administered intramuscularly or subcutaneously, allowing for rapid absorption into the bloodstream. The onset of immune response may vary, but typically, peak antibody levels can be observed within weeks to months post-vaccination. The duration of immunity also varies based on the specific vaccine and the antigens included.

Pregnancy

Bivalent vaccines have not shown teratogenic effects in animal studies, but data on human pregnancy is limited. Consult healthcare providers before administration.

Breast-feeding

Limited data is available on the effects of bivalent vaccines during breastfeeding. Generally considered safe, but consult healthcare providers for individual assessment.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze. Protect from light.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.